| Institution: | 1. Unité de rétine, département d’ophtalmologie, hôpital Pierre-Paul-Riquet, CHU de Toulouse, place du Dr-Baylac, 31059 Toulouse cedex 9, France;2. Université Toulouse III Paul-Sabatier, 118, route de Narbonne, 31062 Toulouse, France;3. Service de pharmacologie médicale et clinique, UMR Inserm 1027, CIC Inserm 1436, faculté de médecine, CHU de Toulouse, 31000 Toulouse, France;4. Anesthésie-réanimation, clinique Pasteur, avenue de Lombez, 31300 Toulouse, France;5. Département d’anesthésie et soins intensifs, hôpital Pierre-Paul-Riquet, CHU de Toulouse, place du Dr-Baylac, 31059 Toulouse cedex 9, France;1. Bellvitge University Hospital, Ophthalmology Department, Carrer de la Feixa Llarga, s/n, L’Hospitalet de Llobregat, 08907, Barcelona, Spain;2. Sant Joan de Deu Hospital, Ophthalmology Department. Pediatric Intraocular''s tumours Unit, Passeig de Sant Joan de Déu, 2, Barcelona, Catalunya 08950, Spain;3. Barcelona Children''s Hospital Sant Joan de Déu, Oncology Department, Pediatric Intraocular''s tumours Unit, 78423 Barcelona, Spain;4. Barcelona Children''s Hospital Sant Joan de Déu, Anesthesiology Department, Pediatric Intraocular''s tumours Unit, 78423 Barcelona, Spain;1. Lions Outback Vision, Lions Eye Institute, Nedlands, 1649-035 Western Australia, Australia;2. Vitreoretinal Unit, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia;3. Vision Sciences Study Centre, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal;4. Centre for Ophthalmology and Visual Science, University of Western Australia, Nedlands, Western Australia, Australia |
